IHH Healthcare Berhad (5225.KL)
MYR 6.88
(0.29%)
MYR 6.88
(0.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 6.28 Billion MYR | -5.14% |
| 2022 | 4.09 Billion MYR | 10.27% |
| 2021 | 4.31 Billion MYR | 71.69% |
| 2020 | 2.45 Billion MYR | -22.04% |
| 2019 | 2.94 Billion MYR | 56.73% |
| 2018 | 2 Billion MYR | -19.25% |
| 2017 | 2.45 Billion MYR | 26.92% |
| 2016 | 1.88 Billion MYR | -8.83% |
| 2015 | 2.06 Billion MYR | 6.69% |
| 2014 | 2 Billion MYR | 23.19% |
| 2013 | 1.59 Billion MYR | -4.28% |
| 2012 | 1.73 Billion MYR | 47.89% |
| 2011 | 787.69 Million MYR | 36.51% |
| 2010 | 654.69 Million MYR | 507.76% |
| 2009 | 49.47 Million MYR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.26 Billion MYR | 17.06% |
| 2024 Q2 | 1.26 Billion MYR | 2.54% |
| 2023 Q3 | 1.53 Billion MYR | 84.33% |
| 2023 Q4 | 982.44 Million MYR | -35.79% |
| 2023 FY | - MYR | -5.14% |
| 2023 Q1 | 2.34 Billion MYR | 102.79% |
| 2023 Q2 | 830.09 Million MYR | -64.63% |
| 2022 FY | - MYR | 10.27% |
| 2022 Q3 | 1.07 Billion MYR | -14.89% |
| 2022 Q2 | 1.26 Billion MYR | 19.54% |
| 2022 Q4 | 1.15 Billion MYR | 7.58% |
| 2022 Q1 | 1.05 Billion MYR | 28.54% |
| 2021 Q1 | 882.46 Million MYR | -29.29% |
| 2021 FY | - MYR | 71.69% |
| 2021 Q4 | 822.76 Million MYR | -26.3% |
| 2021 Q3 | 1.11 Billion MYR | -10.62% |
| 2021 Q2 | 1.24 Billion MYR | 41.54% |
| 2020 Q1 | 172.36 Million MYR | -76.07% |
| 2020 FY | - MYR | -22.04% |
| 2020 Q3 | 773.1 Million MYR | 335.68% |
| 2020 Q4 | 1.24 Billion MYR | 61.42% |
| 2020 Q2 | 177.44 Million MYR | 2.95% |
| 2019 Q2 | 741.4 Million MYR | 12.23% |
| 2019 FY | - MYR | 56.73% |
| 2019 Q4 | 720.35 Million MYR | -21.6% |
| 2019 Q3 | 918.8 Million MYR | 23.93% |
| 2019 Q1 | 660.59 Million MYR | -43.94% |
| 2018 Q1 | 384.79 Million MYR | -13.22% |
| 2018 FY | - MYR | -19.25% |
| 2018 Q4 | 1.17 Billion MYR | 1953.92% |
| 2018 Q3 | -63.56 Million MYR | -109.71% |
| 2018 Q2 | 654.58 Million MYR | 70.11% |
| 2017 Q3 | 431.63 Million MYR | -40.21% |
| 2017 FY | - MYR | 26.92% |
| 2017 Q1 | 784.75 Million MYR | 328.03% |
| 2017 Q2 | 721.86 Million MYR | -8.01% |
| 2017 Q4 | 443.4 Million MYR | 2.73% |
| 2016 FY | - MYR | -8.83% |
| 2016 Q1 | 606.26 Million MYR | -24.93% |
| 2016 Q4 | 183.34 Million MYR | -60.77% |
| 2016 Q3 | 467.33 Million MYR | -26.57% |
| 2016 Q2 | 636.46 Million MYR | 4.98% |
| 2015 FY | - MYR | 6.69% |
| 2015 Q3 | 299.6 Million MYR | -44.61% |
| 2015 Q2 | 540.86 Million MYR | 26.15% |
| 2015 Q1 | 428.76 Million MYR | -28.72% |
| 2015 Q4 | 807.55 Million MYR | 169.54% |
| 2014 Q3 | 385.66 Million MYR | -27.27% |
| 2014 Q2 | 530.27 Million MYR | 23.56% |
| 2014 Q1 | 429.17 Million MYR | -7.54% |
| 2014 FY | - MYR | 23.19% |
| 2014 Q4 | 601.48 Million MYR | 55.96% |
| 2013 FY | - MYR | -4.28% |
| 2013 Q1 | 384.24 Million MYR | 134.36% |
| 2013 Q4 | 464.14 Million MYR | 34.03% |
| 2013 Q3 | 346.31 Million MYR | -10.17% |
| 2013 Q2 | 385.5 Million MYR | 0.33% |
| 2012 FY | - MYR | 47.89% |
| 2012 Q2 | 725.44 Million MYR | 108.51% |
| 2012 Q1 | 347.91 Million MYR | 0.0% |
| 2012 Q3 | 370.63 Million MYR | -48.91% |
| 2012 Q4 | 163.95 Million MYR | -55.76% |
| 2011 FY | - MYR | 36.51% |
| 2010 FY | - MYR | 507.76% |
| 2009 FY | - MYR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| TMC Life Sciences Berhad | 90.78 Million MYR | -6819.255% |
| KPJ Healthcare Berhad | 814.46 Million MYR | -671.222% |